Biomarker– tag –
-
MDPI: Nanomaterial & AI-Enhanced Biosensors Modernize Asthma Diagnostics, Enabling Low-Concentration Detection of Salivary IL-8 and Other Biomarkers
MDPI Switzerland Overview Biosensors enhanced by nanomaterials and artificial intelligence are driving the modernization of asthma diagnostics. Optical biosensors are gaining popularity due to their real-time, label-free detection capabi... -
Convergence Reports on Next-Gen Wearable Biosensors Using Aptamers for Real-time Molecular Health Monitoring
Convergence Netherlands Overview Dr. Alina Rwei's research team is developing next-generation wearable biosensors that measure biomarkers from minute bodily fluids like sweat and interstitial fluid. These miniature devices aim to track b... -
Exosome Clinical Trials Hit ~90 Globally in 2026: Advancing Regenerative Medicine, Diagnostic Biomarkers, and Drug Delivery
OmniGenix USA Overview A new peer-reviewed analysis in 2026 reveals approximately 90 exosome-related human clinical trials registered globally, showcasing diverse applications from cancer diagnostics to joint repair. Exosomes are being i... -
ASCO Annual Meeting 2026 Signals New Era in Lung Cancer Treatment: Adjuvant Targeted Therapy and ADCs Reshape Immunotherapy Strategies
Targeted Oncology USA Overview Targeted Oncology reports that three key lung cancer abstracts from the ASCO 2026 Annual Meeting could significantly alter clinical practice. These presentations highlight advances in adjuvant targeted ther... -
Fate Therapeutics’ iPSC-Derived CAR-T FT836 Shows Early Phase 1 Data Suggesting Colorectal Tumor Shrinkage with Nine Engineered Edits
CRISPR Medicine News USA Overview Fate Therapeutics has announced initial Phase 1 data for FT836, an iPSC-derived, off-the-shelf CAR-T cell therapy. In a trial involving nine colorectal cancer patients, reductions in target lesion size a... -
Genomics Launches AI Platform ‘Mystra AI’ to Streamline Drug Discovery and Validation, with Anticipated Ripple Effects on Biomanufacturing Optimization
Biology Digital UK Overview Biotechnology firm Genomics officially launched 'Mystra AI,' an AI platform designed to significantly streamline drug discovery and validation processes. Built upon advanced machine learning models trained on ... -
Umeå University Breakthrough: ‘Plastic Antibodies’ Advance Detection of Challenging Hydrophilic Analytes
Umeå University スウェーデン Overview Chau Minh Huynh at Umeå University has developed pioneering molecularly imprinted monoliths (MIPs), often termed 'plastic antibodies,' specifically engineered to target challenging hydrophilic analyt... -
Cambridge University & GlitterinTech Develop $10 Spectrometer Chip Delivering Lab-Grade Chemical Analysis for Non-Invasive Wearable Biomarker Monitoring
Rasayanika UK Overview Researchers from Cambridge University and GlitterinTech have developed a compact spectrometer chip costing approximately $10, capable of lab-grade chemical analysis. This centimeter-scale chip holds the potential f... -
Integrating AI with Wearable Sensors: A Future for Advanced Health Monitoring and Early Disease Diagnosis
MDPI (Sensors Journal) Switzerland, International Overview A review paper in MDPI's Sensors journal explores how artificial intelligence (AI) and machine learning (ML) enhance wearable sensors for advanced data analysis, pattern recognit... -
FiberSense AG Secures CE Mark for Groundbreaking 28-Day Optical CGM System, Targeting European Market Entry
PR Newswire (The Storm Media経由) Switzerland, EU Overview Swiss medtech firm FiberSense AG has obtained CE Mark approval for its continuous glucose monitoring (CGM) system as a Class IIb medical device under EU Regulation 2017/745. This...
